Viera Muzithras

Vice President at Be Bio

Viera Muzithras has extensive experience in regulatory affairs, currently serving as Vice President at Be Biopharma since July 2023. Previously, Viera held the position of Vice President at TCR² Therapeutics Inc. from May 2020 to July 2023 and worked at Celgene in a regulatory affairs role from July 2016 to May 2020. Viera's career includes significant positions at Novartis as Senior Director of Regulatory Affairs, Bayer HealthCare, sanofi-aventis, Pfizer, and Lederle/Wyeth, demonstrating a long-standing commitment to regulatory matters within the biopharmaceutical industry.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Be Bio

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.


Industries

Employees

51-200

Links